Author Correction: Molecular basis for integrin adhesion receptor binding to p21-activated kinase 4 (PAK4).

Autor: Ha BH; The Department of Pharmacology, Yale University, 333 Cedar St., New Haven, CT, 06520, USA., Yigit S; The Department of Pharmacology, Yale University, 333 Cedar St., New Haven, CT, 06520, USA., Natarajan N; The Department of Pharmacology, Yale University, 333 Cedar St., New Haven, CT, 06520, USA., Morse EM; The Department of Cell Biology, Yale University, 333 Cedar St., New Haven, CT, 06520, USA., Calderwood DA; The Department of Pharmacology, Yale University, 333 Cedar St., New Haven, CT, 06520, USA. david.calderwood@yale.edu.; The Department of Cell Biology, Yale University, 333 Cedar St., New Haven, CT, 06520, USA. david.calderwood@yale.edu., Boggon TJ; The Department of Pharmacology, Yale University, 333 Cedar St., New Haven, CT, 06520, USA. titus.boggon@yale.edu.; The Department of Molecular Biophysics and Biochemistry, Yale University, 333 Cedar St., New Haven, CT, 06520, USA. titus.boggon@yale.edu.

Publikováno v: Communications biology [Commun Biol] 2023 Jul 31; Vol. 6 (1), pp. 794. Date of Electronic Publication: 2023 Jul 31.

PAK6 targets to cell-cell adhesions through its N-terminus in a Cdc42-dependent manner to drive epithelial colony escape.

Autor: Morse EM; Department of Cell Biology, Yale University School of Medicine, New Haven, CT 06520, USA., Sun X; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA., Olberding JR; Department of Cell Biology, Yale University School of Medicine, New Haven, CT 06520, USA., Ha BH; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA., Boggon TJ; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, CT 06520, USA Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520, USA., Calderwood DA; Department of Cell Biology, Yale University School of Medicine, New Haven, CT 06520, USA Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520, USA david.calderwood@yale.edu.

Publikováno v: Journal of cell science [J Cell Sci] 2016 Jan 15; Vol. 129 (2), pp. 380-93. Date of Electronic Publication: 2015 Nov 23.

A 2013 Survey on Pressure Monitoring in Adult Cardiopulmonary Bypass Circuits: Modes and Applications.

Autor: Rigg L, Searles B, Darling EM

Publikováno v: The journal of extra-corporeal technology [J Extra Corpor Technol] 2014 Dec; Vol. 46 (4), pp. 287-92.

Substrate and inhibitor specificity of the type II p21-activated kinase, PAK6.

Autor: Gao J; State Key Laboratory for Conservation and Utilization of Subtropical Agro-biosciences, The Key Laboratory of Ministry of Education for Microbial and Plant Genetic Engineering, and College of Life Science and Technology, Guangxi University, Nanning, Guangxi, China ; Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United States of America., Ha BH, Lou HJ, Morse EM, Zhang R, Calderwood DA, Turk BE, Boggon TJ

Publikováno v: PloS one [PLoS One] 2013 Oct 28; Vol. 8 (10), pp. e77818. Date of Electronic Publication: 2013 Oct 28 (Print Publication: 2013).

A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold.

Autor: Kemp MM; Broad Institute of Harvard and MIT, Cambridge, MA 02142, United States., Wang Q, Fuller JH, West N, Martinez NM, Morse EM, Weïwer M, Schreiber SL, Bradner JE, Koehler AN

Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2011 Jul 15; Vol. 21 (14), pp. 4164-9. Date of Electronic Publication: 2011 Jun 02.